Something I keep noticing: the analysts who cover Ethereum validator economics have been largely quiet on @get_optimum. The research paper published in March quantified APR uplifts with real relay data. The ETHResearch post is live. Seven major operators representing 15% of total stake have been running testnet. The Hamming Medal was announced. Multiple blog posts, a simulation tool, Cosmos integration activity. By any reasonable signal threshold, this is a project that should be generating more analyst commentary than it has. I have a theory about why. Propagation layer improvements are structurally hard to fit into the standard crypto analyst narrative framework. They don't have a token yet. The economics don't resolve until mainnet, and mainnet doesn't have a confirmed date. The technical claims require understanding erasure coding to evaluate properly. And the validator economics story, while compelling, requires a different mental model than most DeFi or L1 narratives use. Infrastructure projects that solve real problems at the protocol level often get discovered late. The attention tends to front-run the product by one cycle when tokens are involved, or lag the product by one cycle when they aren't. Optimum currently sits in the second pattern. I might be wrong about whether this matters. But the combination of real testnet data, institutional validator adoption, and peer-reviewed research with no commensurate market narrative feels like a gap worth naming. @blockchainjeff

Share







Source:Show original
Disclaimer: The information on this page may have been obtained from third parties and does not necessarily reflect the views or opinions of KuCoin. This content is provided for general informational purposes only, without any representation or warranty of any kind, nor shall it be construed as financial or investment advice. KuCoin shall not be liable for any errors or omissions, or for any outcomes resulting from the use of this information.
Investments in digital assets can be risky. Please carefully evaluate the risks of a product and your risk tolerance based on your own financial circumstances. For more information, please refer to our Terms of Use and Risk Disclosure.
